Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C

The distribution and the mean of the parameters of the patients were as follows: 1009 patients with chronic hepatitis B with a mean age of 45±13/years [emale/male (F/M)=47.5/52.5%] and 290 patients with hepatitis C with a mean age of 52±cut-off value of the REAL TEST formula"[(age x pT x AST)/(PLT/1000)]/100" in patients with hepatitis B was determined to be >=1.37, it was found that it could predict fibrosis with 79% specificity, 78% sensitivity, 85% negative predictive value (NPV), and 70% positive predictive value (PPV) (area under the curve (AUC)=0.852, 95% CI:0.820.87).

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/Aims: To provide a new mathematical formula to predict liver fibrosis in patients with chronic viral hepatitis.

📊

Key Findings & Data:Chronic hepatitis B was defined as immunopositivity for the hepatitis B surface antigen for at least 6 months, and chronic hepatitis C was defined as positivity for HCV RNA for at least 3 months.

💡

Conclusion & Impact:The distribution and the mean of the parameters of the patients were as follows: 1009 patients with chronic hepatitis B with a mean age of 45±13/years [emale/male (F/M)=47.5/52.5%] and 290 patients with hepatitis C with a mean age of 52±cut-off value of the REAL TEST formula"[(age x pT x AST)/(PLT/1000)]/100" in patients with hepatitis B was determined to be >=1.37, it was found that it could predict fibrosis with 79% specificity, 78% sensitivity, 85% negative predictive value (NPV), and 70% positive predictive value (PPV) (area under the curve (AUC)=0.852, 95% CI:0.820.87).

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

Background/Aims: To provide a new mathematical formula to predict liver fibrosis in patients with chronic viral hepatitis. Materials and Methods: Patients with chronic hepatitis B and C who underwent liver biopsy at different centers were included in this study. Chronic hepatitis B was defined as immunopositivity for the hepatitis B surface antigen for at least 6 months, and chronic hepatitis C was defined as positivity for HCV RNA for at least 3 months. The histological features were evaluated by the histological activity index and fibrosis. Results: In total, 1299 patients were included in the study. The distribution and the mean of the parameters of the patients were as follows: 1009 patients with chronic hepatitis B with a mean age of 45±13/years [emale/male (F/M)=47.5/52.5%] and 290 patients with hepatitis C with a mean age of 52±cut-off value of the REAL TEST formula"[(age x pT x AST)/(PLT/1000)]/100" in patients with hepatitis B was determined to be >=1.37, it was found that it could predict fibrosis with 79% specificity, 78% sensitivity, 85% negative predictive value (NPV), and 70% positive predictive value (PPV) (area under the curve (AUC)=0.852, 95% CI:0.820.87). When the cut-off value of the REAL TEST formula in patients with hepatitis C was determined to be >=1.99, it was found that it could predict significant fibrosis with 87% specificity, 90% sensitivity, 94.4% NPV, and 79.4% PPV (AUC:0.95, 95% CI:0.93-0.98)Conclusion: The REAL TEST formula results correlated with the pathological findings and may be a useful method for the evaluation of patients with chronic hepatitis B and C.

🔖

Cite This Article

BUĞDACI, M. S., KORKMAZ, H., DEMİR, A., BIYIK, M., TEMEL, T., GÖKTÜRK, H. S., ÖZAKYOL, A., HATEMİ, A. İ., BAYSAL, B., KARACA, Ç., ŞENTÜRK, H. (2014). Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 5, 539–545. https://ajindex.com/articles/410757

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (12)

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepa- tol 2012; 57: 167-85.
Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: A leading meta-analysis. BMC Gastroenterol 2012; 12: 14. Shin WG, Park SH, Jun SY, et al. Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases. Gut Liver 2007; 1: 145-50.
Hung HH, Su CW, Lai CR, et al. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatol Int 2010; 4: 691-9.
Bugdaci MS, Alkim C, Karaca C, Kesici B, Bayraktar B, Sokmen M. Could complement C4 be an alternative to biopsy for chronic hepatitis B histopathologic findings?. J Clin Gastroenterol 2011; 45: 449-55.
Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatol- ogy 2009; 50: 661-2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepa- tol 2009; 50: 227-42.
Shin WG, Park SH, Jang MK, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hep- atitis B. Dig Liver Dis 2008; 40: 267-74.
Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver dis- eases: Diagnosis and management. J Hepatol 2005; 42 Suppl (1): S22-36. Bravo AA, Sheth SG, Chopra S. Liver Biopsy. N Engl J Med 2001; 344: 495-500.
Friedrich-Rust M, Ong MF, Herrmann E, et al. Real-time elastog- raphy for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007; 188: 758-64.
Silva Jr RG, Fakhouri R, Nascimento TV, Santos IM. Aspartate ami- notransferase-to-platelet ratio index for fibrosis and cirrhosis pre- diction in chronic hepatitis C patients. Braz J Infect Dis 2008; 12: 15-9.
Chang PE, Lui HF, Chau YP, et al. Prospective evaluation of tran- sient elastography for the diagnosis of hepatic fibrosis in Asians: Comparison with liver biopsy and aspartate transaminase plate- let ratio index. Aliment Pharmacol Ther 2008; 28: 51-61.
Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 2004; 127: 1704-13.
Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Nonin- vasive assessment of liver fibrosis with combined serum amino- transferase/platelet ratio index an